Impact on bone microarchitecture and failure load in a patient with type I Gaucher disease who switched from Imiglucerase to Eliglustat

Publication date: September 2020Source: Molecular Genetics and Metabolism Reports, Volume 24Author(s): Karamjot Sidhu, Steven K. Boyd, Aneal Khan

Source: Molecular Genetics and Metabolism Reports - June 1, 2020 Category: Genetics & Stem Cells Source Type: research